Special Issue "Nanoparticle-Enhanced Radiotherapy"
Deadline for manuscript submissions: closed (25 December 2020) | Viewed by 13092
Interests: artificial intelligence; machine learning; computer simulation; high-performance computing; cloud computing; big data; radiotherapy; health care; nanotechnology; image processing; radiation treatment planning; chatbot; radiation dosimetry; dna damage; radiobiological modelling
Special Issues, Collections and Topics in MDPI journals
This Special Issue of Nanomaterials will cover the most recent advances of the theoretical and experimental studies in nanoparticle-enhanced radiotherapy. Recently, there are many studies on how nanoparticles are added to the tumor to enhance the amount of cancer cells killed in radiotherapy. Adding nanoparticles, such as gold, as heavy-atom radiosensitizers to the tumor, results in a radiation dose and image contrast enhancement. In cancer treatment, such an addition of radiosensitizer can deliver a radiation dose directly to the tumor, while sparing the surrounding tissue. As this radiosensitizer enhances the contrast of the tumor in the medical imaging, the accuracy of the radiation beam targeting is increased. The radiosensitizer also improves the dose absorption in the tumour and the cancer cells killed. The study of nanoparticle-enhanced radiotherapy is multidisciplinary, consisting of different fields, namely, radio-pharmacy, radiobiology, computer simulation, medical and clinical science, and so on. These studies contributed to different components in the nanoparticle-enhanced radiotherapy chain to determine the best strategy of applying nanoparticles in the cancer treatment with the best patient outcome.
This Special Issue calls for papers on all theoretical and experimental studies in various aspects of nanoparticle-enhanced radiotherapy. Theoretical studies include the interaction between radiation and nanoparticles, the design of heavy-atom radiosensitizers, radiobiology of DNA damage as a result of nanoparticles, Monte Carlo simulations on radiation dose and image contrast enhancement, and so on. Experimental studies include the fabrication of nanoparticles, nanoparticle delivery to the cancer cell, as well as related cellular, preclinical, and clinical models.
Dr. James Chow
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Fabrication and synthesis
- Nanoparticle delivery to cancer cells
- Monte Carlo simulation
- Radiation interaction
- Dose enhancement
- Image contrast enhancement
- Preclinical and clinical model
- Cellular model
- Heavy-atom radiosensitizer